RCP
GWPH

Rothschild Capital Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Rothschild Capital Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,560
Closed -$3.13M – 81
2016
Q3 		$3.13M Buy
23,560
+20,560
+685% +$1.96M 1.13% 33
2016
Q2 		$275K Buy
+3,000
New +$253K 0.11% 50

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rothschild Capital Partners's GWPH Position: Q4 2016 in Review

Rothschild Capital Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016, closing a stake of 23,560 shares — an estimated $3.13M sold.

Rothschild Capital Partners first reported a position in GWPH in Q2 2016 and held it in 2 quarters. The position peaked at $3.13M in Q3 2016. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

  • Rothschild Capital Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2016 after selling out during the quarter.
  • Rothschild Capital Partners sold 23,560 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $3.13M.
  • Rothschild Capital Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 2 quarters.
  • Rothschild Capital Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.13M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on Rothschild Capital Partners's 13F filing for Q4 2016, filed 30 Jan 2017.